U.S. Dialysis Services Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Dialysis Services Market Trends and Insights

Rising ESKD Treatment Population Drives Structural Demand

The United States dialysis services market is growing steadily due to the increasing need for long-term renal replacement therapy. Between 2002 and 2022, end-stage kidney disease (ESKD) cases rose by 31.3%, with prevalence increasing by 20,000 cases annually. Over 808,000 Americans live with ESKD, and 68% depend on dialysis, creating a stable demand. Medicare coverage ensures financial stability, while CMS projects USD 6 billion in payments to 7,600 ESRD facilities by 2026, driving investments in clinical infrastructure.^{[3]JAMA Network Open, “Expansion and Marketing of Medicare Advantage to Persons With End-Stage Kidney Disease,” JAMA Network Open, jamanetwork.com} Providers focusing on long-term care management across diverse settings are better positioned for growth.

Aging Demographics and Diabetes Prevalence Compound Patient Volumes

Diabetes and hypertension remain key drivers of renal disease in the United States, with aging demographics further compounding the burden. Black Americans face over four times the risk of developing ESKD compared to White Americans, while Hispanic and Native American populations are more than twice as likely to be affected. These disparities shape demand in specific regions, requiring providers to align staffing, referrals, and support services with local needs. Operators addressing high-burden populations through tailored expansions and care coordination are better equipped to manage growing patient volumes and ensure quality outcomes.

Home Dialysis Adoption Push Reconfigures the Care Delivery Footprint

The United States dialysis services market is transitioning toward home-based treatment models, supported by evolving reimbursement policies. CMS has expanded Medicare coverage to include home dialysis for acute kidney injuries and broadened payment adjustments for home and self-dialysis training. Home dialysis requires robust training, patient readiness, and clinical support, making it a gradual but clear shift from center-based care. Providers investing in onboarding systems, training teams, and patient support infrastructure are well-positioned to adapt to changing treatment modalities and enhance patient retention.

Medicare Advantage ESRD Enrollment Transforms Payer Dynamics

Medicare Advantage has significantly impacted the United States dialysis market, with enrollment among dialysis patients rising from 24.8% in December 2020 to 47% by December 2022. This shift emphasizes the importance of network design, utilization reviews, and care authorizations in revenue management. Independent and regional operators must prioritize contract negotiations and referral strategies in competitive markets. The trend also accelerates integrated kidney care models, as payers seek improved hospitalization management and coordinated care pathways. DaVita's risk-based portfolio, managing over USD 5 billion in medical costs, highlights the growing focus on value-based kidney care.

Nurse and Technician Shortages Constrain Treatment Capacity Expansion

In 2026, workforce shortages continue to constrain the United States dialysis services market, as dialysis delivery relies on skilled nurses, technicians, and support staff. Nearly 25% of full-time nephrology social workers plan to resign within the year, highlighting staffing challenges that extend beyond direct care roles. CMS Conditions for Coverage mandate specific staffing and care protocols for ESRD facilities, making staffing gaps a critical issue affecting scheduling, compliance, and patient access. Rural areas face the greatest impact due to limited recruitment pools and travel distances, while smaller operators struggle with fewer resources to reassign staff. Persistent shortages may hinder capacity growth, particularly in fragile local markets.

Medicare Reimbursement Structure Limits Margin Recovery

The ESRD PPS base rate increases to USD 281.71 per treatment in 2026 from USD 273.82 in 2025, but margin pressures persist due to Medicare's dominant payer mix. With 76% of dialysis patients on Medicare and 43% dually eligible for Medicare and Medicaid, providers face limited pricing flexibility. The termination of the ESRD Treatment Choices Model at the end of 2025 removes a key pathway supporting home dialysis and value-based care. Commercial insurance covers only a small portion of patients, leaving providers exposed to rising costs, staffing challenges, and care-quality demands that outpace reimbursement adjustments.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Modality: In-Center Scale Remains Dominant While Home Modalities Gain Momentum

In 2025, In-Center Hemodialysis accounted for 65.35% of the United States dialysis services market, driven by established infrastructure, physician familiarity, and operational routines. Many patients begin and stabilize treatment in clinical settings before transitioning to home options. Fresenius Medical Care reported that nearly 90% of in-center dialysis machines in the United States are their devices, highlighting the role of equipment standardization. Peritoneal dialysis, while smaller in share, remains relevant as it enables treatment outside clinics while maintaining provider-patient relationships.

Home Hemodialysis is projected to grow at a 7.12% CAGR through 2031, making it the fastest-growing modality. CMS's expansion of home and self-dialysis training payments for acute kidney injury patients under the CY2025 ESRD PPS rule reduces cost barriers, encouraging providers to invest in home treatment systems. The market is shifting toward a balanced modality mix, emphasizing patient preparation and home support alongside treatment delivery. Fresenius plans to exit underperforming clinics in 2026 while advancing its 5008X CAREsystem rollout, reflecting network and technology optimization.

By Site of Care: Freestanding Centers Lead While Home-Based Care Gains Ground

Freestanding Outpatient Dialysis Centers held a 69.67% share in 2025, maintaining their lead in the United States dialysis services market due to operational efficiency and scale under the ESRD PPS framework. CMS's 2026 payment increase of 2.2% for freestanding centers, compared to 1.5% for hospital-based facilities, further strengthens their economic position. Hospital-Based Dialysis Centers remain essential for higher-acuity patients and inpatient starts requiring closer monitoring.

Patient Home Dialysis is forecasted to grow at an 8.35% CAGR through 2031, driven by improved reimbursement, training payments, and portability. The CY2025 ESRD PPS rule's expansion of acute kidney injury home dialysis coverage supports this growth. Skilled nursing and post-acute settings also play a role, particularly for older and complex patients transitioning through multiple care settings. Future site-of-care dynamics will depend on seamless coordination of home onboarding, transport, and follow-up care.

By Service Type: Treatment Delivery Holds the Revenue Base While Training Services Grow Fastest

In 2025, Dialysis Treatment Delivery Services represented 56.45% of the United States dialysis services market, reflecting the recurring nature of dialysis and predictable billing under standardized reimbursement. CMS's 2026 base rate of USD 281.71 per treatment reinforces the centrality of treatment delivery in provider economics. Acute and inpatient dialysis services cater to higher-acuity patients with distinct billing pathways.

Home Dialysis Training and Support Services are projected to grow at an 8.63% CAGR through 2031, indicating a shift toward education, monitoring, and support for scalable home care. Renal care coordination services are gaining importance as providers focus on cost management, hospitalization reduction, and patient tracking. DaVita reported managing over USD 5 billion in total medical costs under value-based care arrangements in 2026, highlighting the strategic value of integrated support services.

By Provider Type: Large Organizations Lead While Health-System Providers Expand Faster

Large Dialysis Organizations held a 55.89% share in 2025, leveraging scale advantages such as national purchasing, payer negotiations, and operational efficiency across extensive clinic networks. Decades of market presence have also fostered patient familiarity and referral patterns. However, local trust, nonprofit positioning, and regional integration remain critical for competitive success, as demonstrated by organizations like Northwest Kidney Centers and Satellite Healthcare.

Hospital and Health-System Affiliated Providers are forecasted to grow at a 6.90% CAGR through 2031, supported by direct hospital referrals, smoother transitions for inpatient dialysis starts, and continuity between acute and chronic care. Independent regional providers and nephrologist-led models remain relevant in markets where physician relationships influence patient direction. Future competition will focus on integrating dialysis delivery, home capabilities, and care coordination rather than solely expanding clinic networks.

Geography Analysis

In the United States dialysis services market, the South faces the highest disease burden, with an adjusted end-stage kidney disease incidence of 434 per million population. This is driven by higher rates of diabetes, hypertension, and racial disparities in states like Arkansas, Louisiana, Texas, and Oklahoma. Elevated patient density in these regions increases demand for freestanding centers and home dialysis training. Clinic closures, staffing shortages, or referral delays in rural Southern markets significantly impact access compared to lower-burden regions.

The Northeast experiences the lowest burden, with an end-stage kidney disease incidence of 284.6 per million population, nearly 35% lower than the South. This reflects better early detection of chronic kidney disease, timely nephrology referrals, and fewer comorbidities linked to kidney failure. The Midwest falls in between but faces challenges in rural areas due to limited staffing and weaker site economics, making it more susceptible to service disruptions from labor shortages or network adjustments.

The West and Southwest present a mixed scenario in the United States dialysis services market. Urban areas support multi-provider competition, advanced home dialysis capabilities, and better access to specialists, while rural and frontier regions face longer travel distances and limited service redundancy. Regional performance depends on disease burden, workforce availability, and home treatment feasibility, with opportunities strongest where providers adapt to local clinical needs instead of applying a uniform national approach.